These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
    Author: Singh S, Bouzinbi N, Chaturvedi V, Godreuil S, Kremer L.
    Journal: Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732.
    Abstract:
    The in vitro susceptibility profile to amikacin, linezolid, clarithromycin, imipenem, cefoxitin, clofazimine and tigecycline was established for 67 strains belonging to the Mycobacterium abscessus complex. Clofazimine and tigecycline were among the most effective drugs, prompting us to assess the effect of a clofazimine and tigecycline combination. Synergistic activity was found in 42% of the 19 isolates tested. The clinical impact of this new drug combination against the M. abscessus complex, as an alternative or sequential medication for the treatment of drug-resistant strains, remains to be addressed.
    [Abstract] [Full Text] [Related] [New Search]